Literature DB >> 2580419

Polyagglutinability due to loss of O-antigenic determinants in Pseudomonas aeruginosa strains isolated from cystic fibrosis patients.

B Ojeniyi, L Baek, N Høiby.   

Abstract

O-polyagglutinable P. aeruginosa are prevalent among chronically infected cystic fibrosis patients. In the present work, one O-group 3, one O-group 9 and one polyagglutinable 0-3/9 strain were analysed by use of both corresponding group specific antisera against the O-antigen and polyspecific antisera against all extractable antigens of the 3 strains. Quantitative immunoelectrophoresis and classical tube-agglutination methods were employed in the analysis. The results showed that the polyagglutinable strain contained 0.1% and the 0-9 strain 1%, respectively, of the O-antigen-containing LPS present in the 0-3 strain. It is discussed whether these differences represent a gradual antigenic adjustment to the defence mechanisms of the chronically infected patients.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2580419     DOI: 10.1111/j.1699-0463.1985.tb02844.x

Source DB:  PubMed          Journal:  Acta Pathol Microbiol Immunol Scand B        ISSN: 0108-0180


  15 in total

1.  Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.

Authors:  E Bingen; E Denamur; B Picard; P Goullet; N Lambert-Zechovsky; P Foucaud; J Navarro; J Elion
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-05       Impact factor: 3.267

2.  Heterogeneity, persistence, and distribution of Pseudomonas aeruginosa genotypes in cystic fibrosis patients.

Authors:  M Fegan; P Francis; A C Hayward; J A Fuerst
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

3.  Adherence to and penetration of human intestinal Caco-2 epithelial cell monolayers by Pseudomonas aeruginosa.

Authors:  Y Hirakata; K Izumikawa; T Yamaguchi; S Igimi; N Furuya; S Maesaki; K Tomono; Y Yamada; S Kohno; K Yamaguchi; S Kamihira
Journal:  Infect Immun       Date:  1998-04       Impact factor: 3.441

4.  Growth-dependent alterations in production of serotype-specific and common antigen lipopolysaccharides in Pseudomonas aeruginosa PAO1.

Authors:  E J McGroarty; M Rivera
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

5.  Phenotypic conversion of Pseudomonas aeruginosa in cystic fibrosis.

Authors:  M Fegan; P Francis; A C Hayward; G H Davis; J A Fuerst
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

Review 6.  Use of ribotyping in epidemiological surveillance of nosocomial outbreaks.

Authors:  E H Bingen; E Denamur; J Elion
Journal:  Clin Microbiol Rev       Date:  1994-07       Impact factor: 26.132

7.  Occurrence of a common lipopolysaccharide antigen in standard and clinical strains of Pseudomonas aeruginosa.

Authors:  M Y Lam; E J McGroarty; A M Kropinski; L A MacDonald; S S Pedersen; N Høiby; J S Lam
Journal:  J Clin Microbiol       Date:  1989-05       Impact factor: 5.948

Review 8.  Cystic fibrosis. Infection and immunity to Pseudomonas.

Authors:  R U Sorensen; R L Waller; J D Klinger
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

9.  Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis.

Authors:  A Fomsgaard; R S Conrad; C Galanos; G H Shand; N Høiby
Journal:  J Clin Microbiol       Date:  1988-05       Impact factor: 5.948

10.  Identification of outer membrane proteins as target antigens of Pseudomonas aeruginosa Homma serotype M.

Authors:  S Yokota
Journal:  Clin Diagn Lab Immunol       Date:  1995-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.